Highlights AbbVie Inc.

Equities

ABBV

US00287Y1091

Real-time Estimate Cboe BZX Other stock markets 03:01:53 2024-06-11 pm EDT			5-day change	1st Jan Change
168.4 ^USD	-1.22%		+3.76%	+8.56%

11:27am	Alvotech Expands Alliance with STADA to Include Denosumab Biosimilar	MT
Jun. 10	Three companies to bet on medical AI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alvotech Expands Alliance with STADA to Include Denosumab Biosimilar	05:27am	MT
Three companies to bet on medical AI	Jun. 10
Global markets live: ABB, Roche, Microsoft, Apple, Tesla...	Jun. 10
Top law firms in US opioid lawsuits to get hundreds of millions in fees	Jun. 07	RE
AbbVie Says Mid-Stage Study of Mirvetuximab Soravtansine to Treat Ovarian Cancer Meets Primary Endpoint	Jun. 06	MT
AbbVie's ovarian cancer therapy succeeds in mid-stage trial	Jun. 06	RE
AbbVie Inc. Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine (ELAHERE®) for High Folate Receptor-Alpha Expressing Platinum-Sensitive Ovarian Cancer	Jun. 06	CI
Global markets live: Inditex, Intel, TSMC, Dollar Tree, AbbVie...	Jun. 05
AbbVie Says First Patient Treated in Phase 3 Trial Assessing Potential Blood Cancer Treatment	Jun. 05	MT
AbbVie Advances Oncology Pipeline with Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383	Jun. 05	CI
AbbVie Says Arthritis Treatment Rinvoq Now Available for Certain Pediatric Patients in US	Jun. 04	MT
AbbVie's RINVOQ® (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis	Jun. 04	CI
Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday	May. 31	MT
AbbVie Receives Positive CHMP Opinion for Risankizumab for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis	May. 31	CI
OSE Immuno: towards an evolution of the Board of Directors	May. 30	CF
AbbVie Completes Acquisition of Landos Biopharma	May. 23	MT
AbbVie Inc. completed the acquisition of Landos Biopharma, Inc. from a group of shareholders.	May. 22	CI
Medincell: share price falls after disappointing clinical study	May. 15	CF
AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders	May. 13	MT
Medincell: share price rises on resumption of trading	May. 09	CF

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AbbVie Inc.

Equities

ABBV

US00287Y1091

Highlights

Filters